Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Zinzino AB (publ) (9EE.F)

Compare
12.80
-0.90
(-6.57%)
At close: April 4 at 2:55:28 PM GMT+2
Loading Chart for 9EE.F
  • Previous Close 13.70
  • Open 13.54
  • Bid 12.56 x --
  • Ask 12.78 x --
  • Day's Range 12.80 - 13.54
  • 52 Week Range 5.69 - 14.10
  • Volume 280
  • Avg. Volume 480
  • Market Cap (intraday) 420.44M
  • Beta (5Y Monthly) 1.60
  • PE Ratio (TTM) 29.77
  • EPS (TTM) 0.43
  • Earnings Date --
  • Forward Dividend & Yield 0.26 (1.92%)
  • Ex-Dividend Date May 28, 2024
  • 1y Target Est --

Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. The company operates through two segments, Zinzino and Faun. It offers skincare products including cleansers, face creams, serums, and masks. The company provides coffee, coffee machines, accessories, and cups; immune, omega, and restored supplements; weight management products; gut health supplements; and home health test products. It also sells its products through online. The company was founded in 2005 and is based in Västra Frölunda, Sweden.

www.zinzino.com

242

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 9EE.F

View More

Performance Overview: 9EE.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

9EE.F
78.77%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

9EE.F
232.33%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

9EE.F
1,216.44%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

9EE.F
72.97%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: 9EE.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9EE.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    472.69M

  • Enterprise Value

    433.93M

  • Trailing P/E

    32.11

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.46

  • Price/Book (mrq)

    13.29

  • Enterprise Value/Revenue

    2.12

  • Enterprise Value/EBITDA

    18.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.66%

  • Return on Assets (ttm)

    13.43%

  • Return on Equity (ttm)

    52.11%

  • Revenue (ttm)

    2.21B

  • Net Income Avi to Common (ttm)

    169.17M

  • Diluted EPS (ttm)

    0.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    463.05M

  • Total Debt/Equity (mrq)

    11.93%

  • Levered Free Cash Flow (ttm)

    242M

Research Analysis: 9EE.F

View More

Company Insights: 9EE.F

Research Reports: 9EE.F

View More

People Also Watch